Showing 1,661 - 1,680 results of 101,478 for search '(( 5 non decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.76s Refine Results
  1. 1661

    Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis by Eric N. Ouattara (6890174)

    Published 2019
    “…</p><p>Methods</p><p>We used a mathematical model to compare three potential ART initiation criteria: 1) CD4 <350/μL (<i>ART<350/μL</i>); 2) CD4 <500/<i>μ</i>L (<i>ART<500/μL</i>); and 3) ART at presentation (<i>Immediate ART</i>). …”
  2. 1662
  3. 1663

    Image_1_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons.... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
  4. 1664
  5. 1665

    Figure S1 - The RNA Degradation Pathway Regulates the Function of GAS5 a Non-Coding RNA in Mammalian Cells by Hidenori Tani (169942)

    Published 2013
    “…<p><b>Knockdown of UPF1 increases the expression level of GAS5, and decreases the glucocorticoid-responsive genes.…”
  6. 1666

    Selectivity of PRMT5 inhibition with C220. by Shelby L. Sloan (10803222)

    Published 2021
    “…For all cell lines, effects of PRMT5 inhibition with C220 treatment on biomarkers of PRMT5 activity shows a dose-dependent decrease in global marks of symmetric di-methylarginine (SDMA) and symmetric di-methylation of histone H4 arginine-3 (H4R3me2s) with a minimal effect to PRMT5 or global asymmetric di-methylarginine (ADMA). …”
  7. 1667
  8. 1668
  9. 1669
  10. 1670
  11. 1671
  12. 1672
  13. 1673
  14. 1674
  15. 1675
  16. 1676
  17. 1677

    Genes correlated with SARS-CoV-2 viral load over time are similarly expressed in independent datasets of SARS-CoV-2 infected lung and upper airway cells. by Vasanthi Avadhanula (259546)

    Published 2025
    “…<p><b>(a)</b> Differential expression patterns for the 112 genes correlated with SARS-CoV-2 viral load across our serial sampling cohort (p<0.001, from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317033#pone.0317033.g003" target="_blank">Fig 3A</a>) were examined in two independent RNA-seq datasets of SARS-CoV-2 infection: one of lung cancer cell lines (A549 and Calu-3) infected with SARS-CoV-2 at multiplicity-of-Infection (MOI) of 2 for 24 hours (in biological triplicate)[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317033#pone.0317033.ref028" target="_blank">28</a>], and one of nasopharyngeal/oropharyngeal samples in 238 patients with COVID-19, other viral, or non-viral acute respiratory illnesses [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317033#pone.0317033.ref029" target="_blank">29</a>]. …”
  18. 1678

    A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

    Published 2015
    “…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”
  19. 1679
  20. 1680